Marked effects of extreme levels of lipoprotein(a) on estimation of low-density lipoprotein cholesterol

Clinical Biochemistry

Volumn 47, Issue 12, 2014, Pages 1098-1099

  Saeedi, Ramesh ^a   Li, Min ^a   Allard, Matt ^a   Frohlich, Jiri ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dahlen equation; Friedewald equation; LDL C; Lipoprotein(a)

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHODOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETROSPECTIVE STUDY; BLOOD;

CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; RETROSPECTIVE STUDIES;

EID: 84905736895     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.04.023     Document Type: Article

References (8)

1. Dahlen G.H. Incidence of Lp(a) among populations. Lipoprotein(a) 1990, 151-173. Academic Press, New York. A.M. Scanuu (Ed.).
2. Nordestgaard B.G., Chapman M.J., Ray K., Borén J., et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010, 31(23):2844-2853.
3. Li K.M., Wilcken D.E., Dudman N.P. Effect of serum lipoprotein(a) on estimation of low-density lipoprotein cholesterol by the Friedewald formula. Clin Chem 1994, 40(4):571-573.
4. Kamstrup P.R., Tybjærg-Hansen A., Nordestgaard B.G. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol 2013, 61(11):1146-1156.
5. Kamstrup P.R., Benn M., Tybjærg-Hansen A., Nordestgaard B.G. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 2008, 117:176-184.
6. Cantin B., Lamarche B., Després J.P., Dagenais G.R. Does correction of the Friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study. Atherosclerosis 2002, 163:261-267.
7. Jacobson T.A. Lipoprotein(a), cardiovascular disease, and contemporary management. Mayo Clin Proc 2013, 88(11):1294-1311.
8. Kilgore M., Muntner P., Woolley J.M., Sharma P., Bittner V., Rosenson R.S. Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults. J Clin Lipidol 2014, 8(1):86-93.